BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24835032)

  • 1. Prognostic impact of M2 macrophages at neural invasion in patients with invasive ductal carcinoma of the pancreas.
    Sugimoto M; Mitsunaga S; Yoshikawa K; Kato Y; Gotohda N; Takahashi S; Konishi M; Ikeda M; Kojima M; Ochiai A; Kaneko H
    Eur J Cancer; 2014 Jul; 50(11):1900-8. PubMed ID: 24835032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of tumor-associated macrophages on invasive ductal carcinoma of the pancreas head.
    Yoshikawa K; Mitsunaga S; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Aizawa M; Ochiai A
    Cancer Sci; 2012 Nov; 103(11):2012-20. PubMed ID: 22931216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve plexus invasion in pancreatic cancer: spread patterns on histopathologic and embryological analyses.
    Makino I; Kitagawa H; Ohta T; Nakagawara H; Tajima H; Ohnishi I; Takamura H; Tani T; Kayahara M
    Pancreas; 2008 Nov; 37(4):358-65. PubMed ID: 18972625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detail histologic analysis of nerve plexus invasion in invasive ductal carcinoma of the pancreas and its prognostic impact.
    Mitsunaga S; Hasebe T; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Nakagohri T; Ochiai A
    Am J Surg Pathol; 2007 Nov; 31(11):1636-44. PubMed ID: 18059219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapancreatic nerve invasion as a predictor for recurrence after pancreaticoduodenectomy in patients with invasive ductal carcinoma of the pancreas.
    Shimada K; Nara S; Esaki M; Sakamoto Y; Kosuge T; Hiraoka N
    Pancreas; 2011 Apr; 40(3):464-8. PubMed ID: 21289526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of surgical resection for pancreatic carcinoma at a Japanese single cancer institute.
    Nanashima A; Tobinaga S; Abo T; Hatano K; Takeshita H; Nonaka T; Hidaka S; Tanaka K; Kunizaki M; Sawai T; Yasutake T; Nagayasu T
    Hepatogastroenterology; 2012 May; 59(115):911-5. PubMed ID: 22469741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low serum level of cholinesterase at recurrence of pancreatic cancer is a poor prognostic factor and relates to systemic disorder and nerve plexus invasion.
    Mitsunaga S; Kinoshita T; Hasebe T; Nakagohri T; Konishi M; Takahashi S; Gotohda N; Ochiai A
    Pancreas; 2008 Apr; 36(3):241-8. PubMed ID: 18362836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
    Hou YC; Chao YJ; Tung HL; Wang HC; Shan YS
    Cancer; 2014 Sep; 120(17):2766-77. PubMed ID: 24839953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
    Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression.
    Lin CN; Wang CJ; Chao YJ; Lai MD; Shan YS
    BMC Cancer; 2015 Mar; 15():128. PubMed ID: 25872762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment.
    Hirayama S; Ishii G; Nagai K; Ono S; Kojima M; Yamauchi C; Aokage K; Hishida T; Yoshida J; Suzuki K; Ochiai A
    J Thorac Oncol; 2012 Dec; 7(12):1790-1797. PubMed ID: 23154550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of CD204-positive macrophages in upper urinary tract cancer.
    Ichimura T; Morikawa T; Kawai T; Nakagawa T; Matsushita H; Kakimi K; Kume H; Ishikawa S; Homma Y; Fukayama M
    Ann Surg Oncol; 2014 Jun; 21(6):2105-12. PubMed ID: 24492923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type.
    Sadakari Y; Ohuchida K; Nakata K; Ohtsuka T; Aishima S; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Surgery; 2010 Jun; 147(6):812-7. PubMed ID: 20060146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low density of CD204-positive M2-type tumor-associated macrophages in Epstein-Barr virus-associated gastric cancer: a clinicopathologic study with digital image analysis.
    Ichimura T; Abe H; Morikawa T; Yamashita H; Ishikawa S; Ushiku T; Seto Y; Fukayama M
    Hum Pathol; 2016 Oct; 56():74-80. PubMed ID: 27342912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of receptor-tyrosine kinase c-kit protein and TGF-beta1 in invasive ductal carcinoma of the pancreas.
    Nio Y; Omori H; Hashimoto K; Itakura M; Koike M; Yano S; Toga T; Higami T; Maruyama R
    Anticancer Res; 2005; 25(5):3523-9. PubMed ID: 16101174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer.
    Kosuge T; Kiuchi T; Mukai K; Kakizoe T;
    Jpn J Clin Oncol; 2006 Mar; 36(3):159-65. PubMed ID: 16490736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage.
    Waters JA; Schnelldorfer T; Aguilar-Saavedra JR; Chen JH; Yiannoutsos CT; Lillemoe KD; Farnell MB; Sarr MG; Schmidt CM
    J Am Coll Surg; 2011 Aug; 213(2):275-83. PubMed ID: 21601488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
    Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ
    Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection.
    Partelli S; Crippa S; Barugola G; Tamburrino D; Capelli P; D'Onofrio M; Pederzoli P; Falconi M
    Ann Surg Oncol; 2011 Dec; 18(13):3608-14. PubMed ID: 21584836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodal involvement is strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas.
    Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
    Hepatogastroenterology; 2006; 53(69):447-51. PubMed ID: 16795990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.